This seems to be contradictory to the basic understanding of ADAM17-mediated cancer development, where increased EGF-R activity and thus tumorigenesis has been thought to be facilitated by enhanced shedding of EGF-R ligands by ADAM17. Here, EGFR is linked to cancer.